review Open AccessTop 1% cited
Non-alcoholic fatty liver disease – A global public health perspective
Journal of Hepatology · 2018 · Vol. 70(3) · pp. 531–544
Zobair M. Younossi✉(Inova Health System)
Liver Disease Diagnosis and TreatmentLiver Disease and TransplantationAlcohol Consumption and Health EffectsMedicineFatty liverSteatohepatitisCirrhosisDiseaseLiver transplantationLiver diseaseHepatocellular carcinomaInternal medicineAlcoholic liver disease
MeSH terms
ForecastingHumansPublic HealthGlobal HealthCausalityNon-alcoholic Fatty Liver Disease
Funding
- World Health Organization
Citations
2,126
FWCI
114.09
field-weighted impact
References
119
Percentile
100%
vs. same field & year
Citations per year
Cited by
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Journal of Hepatology · 2024 · 1,354 citations
Complications, morbidity and mortality of nonalcoholic fatty liver disease
Metabolism · 2020 · 529 citations
References
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies
The Lancet · 2004 · 12,431 citations
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
Alimentary Pharmacology & Therapeutics · 2011 · 3,085 citations
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Gastroenterology · 2015 · 2,900 citations
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Journal of Hepatology · 2012 · 842 citations
Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
Nutrients · 2013 · 816 citations
Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States
Medicine · 2012 · 561 citations
the Incidence and Risk Factors of Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis
Hepatology · 2010 · 1,287 citations
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
Hepatology · 2014 · 2,228 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.